Barr Pharmaceuticals upgraded to "outperform" - update - newratings.com
|
Barr Pharmaceuticals upgraded to "outperform" - update
newratings.com, Germany - May 13, 2008 Barr Pharmaceuticals is unlikely to witness significant competition for its Yasmin drug through 2010 and the contribution of generic Adderall XR may be … |
Find Out More:
Books:
May 15th, 2008
Adderall

Leave a Reply